News Articles

Trading Room

100+ Years of combined Market Experience!


The BNB Token

One of the strongest ‘alt coins of this year has been Binance coin (BNB).
by Ryan Wilday - 2 days ago


Silver And Oil- A Tale Of Two Directions

In the world of commodities, most market participants pay most attention to the crude oil and precious metals markets. This past week, gold and silver headed higher while the energy commodity went the other way.
by Andy Hecht - 3 days ago


It's Time to Take a Look at Invesco

Invesco is the 13th largest asset manager in the world and offers a variety of products for passive and active investors. They operate the popular QQQ ETF and a variety of factor-based ETF strategies. I particularly like their lead in equal-weight strategies.
by Lyn Alden Schwartzer - 4 days ago


Market Highs: Where is Your Portfolio?

If you are a long-term investor, your portfolio should reflect your personal needs and goals, risk tolerance, and market conditions. There are many reasons why you should not be “beating the market.” Here are some of the most important.
by Jeff Miller - 5 days ago


Building Permits Tumble In June - Are The Low Interest Rates Helping?

The housing starts and building permits report is one of my favorite data points on the housing market and can also be one of the earliest leading indicators in the economy.
by Eric Basmajian - 6 days ago


Fate Therapeutics: Novel iPSC-derived Cell Therapy Oncology Platform but Adequately Valued

Fate Therapeutics (FATE) has a novel iPSC derived cell therapy platform which could be disruptive to the currently first generation CAR-T therapies. The stock however, is adequately valued at present according to my calculations. I am keeping it on my watchlist and will be looking to start a long position with 3-4 years time-frame on a pullback. I will post a follow-up note when I decide to enter a long position in the stock.
by Bhavneesh Sharma - 1 week ago

The Stock Market Has Entered A Danger Zone

Our long-term target/resistance has been in the 3011-45SPX for quite a number of years, and on Friday, we have finally moved into this target. I believe this target has the potential to provide us with a significant market top.
by Avi Gilburt - 1 week ago


I Am Not Surprised By The Lack Of Action In Silver

I am not surprised by the lack of bullish price action in the silver market. However, it would not surprise me if we woke up one morning and found the price appreciably higher and above the $16.20 level. A technical breakout in the silver market could trigger a herd of buying in the metal attracting speculators and investors.
by Andy Hecht - 1 week ago

The Huawei Impact

This week, the Trump administration announced a significant relaxation of its restrictions on US companies selling to Huawei, saying the ban will only apply to products that are related to national security. The news is positive for now, although licenses could dry up if progress is not made in the trade talks.
by Beth Kindig - 1 week ago


Russian Stocks are Quietly Outperforming

Russia has a lot of problems. They have severe concentration of wealth due to corruption and oligopolistic aspects to their economy. Growth is slow and population levels are stagnant. And yet their stock market is on fire lately.
by Lyn Alden Schwartzer - 1 week ago


Bitcoin/GBTC Update

We've seen some nice impulsive follow through on the bearish counts, and until I see an impulsive structure to the upside I'll be looking down, even to $4300 BTC and $157 Ethereum, if this market wants to roll that far, though I'm a bit skeptical it will.
by Ryan Wilday - 1 week ago

Bitcoin Conference Review and Institutional Adoption

A large percentage of the speakers at the Bitcoin Conference, which occurred in the last week of June, are long-term investors in Bitcoin. There are a few reasons why the leading cryptocurrency would be a reliable long-term asset over the coming years, with the possibility that it could reach its peak as a new technology with mass adoption in seven to ten years.
by Beth Kindig - 2 weeks ago

The Market Is About Probabilities – Not Certainties

When I look at the stock market in its current structure, as well as the underlying major stocks within the market, it suggests that the greater probability points to a larger degree pullback in the coming weeks/months.
by Avi Gilburt - 2 weeks ago

Adaptive Biotechnologies: Analysis of this recent Immunesequencing space IPO

Adaptive Biotechnologies has a revolutionary platform in immunesequencing. Considering the large target market opportunity and the market cap of rivals like Illumina and Thermo Fisher, shares could have significant room for price appreciation over next several years, though are currently pricey and may have a better entry point.
by Bhavneesh Sharma - 2 weeks ago


The Silver-Gold Ratio Reached A Record Level On The Quarterly Chart

Gold’s ascent does not take silver along for the ride, as the ratio rises to a new peak.
by Andy Hecht - 2 weeks ago

Why I Like Housing Stocks - Part 2

There are many good names in this space, but here are the F.A.S.T. Graph charts for two of them: Lennar Corporation (LEN) and PulteGroup, Inc. (PHM).
by Jeff Miller - 2 weeks ago


Fed Stress Tests, and One Interesting Bank

BancFirst (BANF) is on my watch list as my regional bank of focus to see what the stock does as this rate cycle and economic cycle continue to unfold.
by Lyn Alden Schwartzer - 2 weeks ago

NGM Biopharma: Recent IPO and A Long-term Investment in NASH Space

NGM Biopharma (NASDAQ: NGM) has been on my radar since the IPO after strong insider buying and novel approach towards non-alcoholic steatohepatitis, NASH, which is expected to become the number one cause of liver transplant in the U.S. by 2020.
by Bhavneesh Sharma - 3 weeks ago

I Am A Long Term Bull, But . . .

I don't think this market tops out until around the 2022/23 time frame, with the potential to rally as high as the 3800-4100SPX region within that time frame. But, that is not the same as saying that I think the market is going directly to that region right now.
by Avi Gilburt - 3 weeks ago

What To Look Forward To In Q3

Q3 and the second half of 2019 is likely to be a volatile time in markets. Fasten those seatbelts; we could be in for a wild ride.
by Andy Hecht - 3 weeks ago

I Bought Sprott Inc. Here's Why.

One of my recent investments was a position in Sprott Inc, which is an alternative asset manager that focuses primarily on precious metals and to a lesser extent on other natural resource investments.
by Lyn Alden Schwartzer - 3 weeks ago


Elections and Investing

The Iowa caucuses are only seven months away! For those who can hardly wait, you probably spent a couple of hours last night watching ten Democrats "debate" policy issues. Ten more are on tap for tonight. And that doesn't cover the whole field.
by Jeff Miller - 3 weeks ago


Home Prices In "Correction" Territory?

Earlier today, two notable housing data points crossed the tape, namely the Case-Shiller Home Price Index "HPI" and the report on New Single-Family Home Sales "NHS". The national HPI reading showed home price growth decelerating yet again to a rate of 3.54% year over year.
by Eric Basmajian - 4 weeks ago


New Buy: Genocea Biosciences: Unique ATLAS Cancer Neoantigen Identification Platform And Attractive Valuation

The recent pullback in Genocea (GNCA) due to the capital raise has resulted in an excellent buying opportunity.
by Bhavneesh Sharma - 1 month ago